Findings Do Not Support Glyburide as First-Line Treatment for Gestational Diabetes - Endocrinology Advisor

Endocrinology Advisor

Findings Do Not Support Glyburide as First-Line Treatment for Gestational Diabetes Endocrinology Advisor The frequency of the primary outcome was 27.6% in the glyburide group and 23.4% in the insulin group. The use of glyburide in gestational diabetes may cause a higher frequency of perinatal complications compared with insulin, according to a new study ...

from diabetes - Google News